Login
Toggle navigation
Videos
Categories
Trending
CKD and Sleeve Gastrectomy - Dr Aleksandra Kukla, Mayo Clinic
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Dr Aleksandra Kukla on CKD and Sleeve Gastrectomy
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Strategies for Sustainable Growth in the Private Credit Market | Patrick Healy, CEO, Hellman & Friedman.
00:10:00
Comparing Donor-Advised Funds and Qualified Charitable Distributions | Mary Grace Graniero - FINANCIAL PLANNER of Howe & Rusling, Inc.
00:00:00
Carl Syubbings, CEO, Benitec Biopharma Ltd
00:10:00
Balancing Act: Navigating Market Neutrality Amid High Valuations | Sébastien Page, CIO , T. Rowe Price.
00:10:00
Understanding Interviews vs. Engagement Centers at BHP
00:10:00
Mr. Marks Analyzes Tax Implications and Market Prospects on CNBC Street Signs Asia: A Comprehensive Discussion with Tanvir Gill and Amanda Drury
00:10:00
Faith and Leadership in the Secular Workplace | Euan Munro , CEO , Newton Investment Management .
00:10:00
Inflation and Interest Rates: Navigating Economic Uncertainty and Investment Strategies | Bill Maldonado, CEO , Eastspring Investments.
00:10:00
Gustavo Chiang, Responsible for Sustainable Development CEMENTOS BIO BIO | ENRIQUE ELSACA HIRMAS, CORPORATE GENERAL MANAGER, Cementos Bio Bio SACEMENTOS:SGO
00:10:00
Vanguard Group appoints Salim Ramji, former BlackRock executive overseeing ETFs and index investing, as its new CEO.
00:10:00
David Rhodes Discusses Inflation, Fed Policies, and Market Impacts
00:10:00
Financial Pulse: June 2024 Market Overview with Michael McCarthy | Michael McCarthy, President, Financial Consulate Inc.